Task force VI: arrhythmias  by Zipes, Douglas P. et al.
lACC Vol. 6, No.6 
December 1985: 1225-32 
Task Force VI: Arrhythmias 
1225 
DOUGLAS p, ZIPES, MD, FACC, CHAIRMAN, LEONARD A, COBB, JR" MD, FACC, 
ARTHUR GARSON, JR" MD, FACC, PAUL C, GILLETTE, MD, FACC, 
THOMAS N, JAMES, MD, FACC, RALPH LAZZARA, MD, FACC, LAWRENCE RINK, MD, FACC 
I. General Considerations 
Establishing the importance of a cardiac rhythm distur•
bance in assessing an athlete eligible for physical compe•
tition is a difficult task for many reasons, Guidelines for 
athletic participation are sought to prevent arrhythmia•
related death or serious symptoms, However, few data exist 
that have been obtained prospectively from well designed, 
scientificalIy acceptable studies to determine whether a par•
ticular rhythm disturbance predisposes an athlete to sudden 
death or to symptoms such as syncope or presyncope that 
could precipitate a severe injury, Sudden cardiac death in 
the young is rare (l,2), It has been estimated that the in•
cidence is less than 1 % of that in adults (3), Nonetheless, 
a significant proportion of these deaths occur in relation to 
exercise, 
Arrhythmias commonly are evanescent, often disap•
pearing unpredictably for long periods of time. If they recur 
when the athlete is not exercising, the arrhythmia may not 
be noted or may not produce significant symptoms. The 
same arrhythmia may minimally bother someone playing 
golf, but severely incapacitate an athlete, such as a cross•
country skier, performing at the peak of physical perform•
ance, Further, since reproducible induction of an arrhythmia 
during exercise testing cannot be achieved in many patients, 
extrapolating this concept to the athlete, it is likely that he 
or she may not develop the arrhythmia during each athletic 
endeavor. Although the reason for this is not clear, factors 
such as the autonomic nervous system probably playa very 
important role in determining whether an arrhythmia occurs, 
its rate and effect on hemodynamic responses and symptoms 
(4). Autonomic "tone" probably varies greatly and, perhaps 
unpredictably, between and within athletic events and from 
one athlete to another. 
Therefore many of our conclusions result from data ob•
tained in nonathletes, from general perceptions and from a 
heavy dose of "what seems reasonable." Decision making 
based on this type of logic often is faulty but is the best 
available, Recommendations and guidance need to be bal•
anced between an effort not to restrict activity unduly and 
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the hope of reducing chances of death and injury due to a 
rhythm disturbance, 
Despite the' 'softness" of most of the information, some 
firm conclusions can be made, Certain arrhythmias create 
symptoms and are dangerous in and of themselves regardless 
of the clinical situation in which they occur (5), These 
arrhythmias generally are characterized by very rapid or very 
slow heart rates that significantly compromise cardiac out•
put, coronary or cerebral blood flow or maintenance of blood 
pressure. Such arrhythmias may include atrial flutter or atrial 
fibrillation with uncontrolled ventricular rates of 200 to 300 
beats/min, usually though not exclusively in patients with 
Wolff-Parkinson-White syndrome, rapid sustained ventric•
ular tachycardias and atrioventricular (A V) block or sinus 
node disease with very slow ventricular rates, Certain per•
sistent arrhythmias, such as chronic supraventricular tachy•
cardia, might, through a periodic inappropriate increase in 
cardiac rate, worsen cardiac function (6), Other arrhythmias 
such as an A V nodal tachycardia, generally well tolerated 
in most patients, may not produce symptoms at rest but only 
in an exercising individual or in patients with other disease 
states such as hypertrophic cardiomyopathy. Arrhythmias 
that might otherwise be innocuous and no more than a nui•
sance might, under conditions of participation in certain 
sports involving body contact or high speed, place the athlete 
at risk of injury or death because of transient loss of control, 
For example, a patient with supraventricular tachycardia 
who is participating in potentially dangerous sports such as 
diving, downhill skiing or auto racing may be at greater risk 
than if he or ~he were playing basketball or baseball. 
Some persons with coronary heart disease (7), hyper•
trophic cardiomyopathy (8,9), aortic stenosis (10) and con•
genital heart disease (I) probably are at an increased risk 
for cardiac arrest and sudden death during and just after 
exercise. This is probably true even if arrhythmias have not 
been recognized previously. This caveat may apply to other 
groups of patients as well, However, persons with mitral 
valve prolapse without mitral insufficiency or other abnor•
malities probably should be considered to have a normal 
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heart (11). Persol1s with symptoms possibly related to car•
diac arrhythmia su~h as syncope, pre syncope and pa!pitation 
should be carefully evaluated before being permitted to par•
ticipate in competitiv~ sports. A consideration of cardiac 
hemodynamic status is critical since ventricular dysfunction 
is probably an additional important predictor of arrhythmir;; 
death (12,13). The presence of a rhythm disturbance in 
patients with severely abnormal cllrdiac hemodynamic st"ltus 
from any cause unrelated to the arrhythmia itself is de~nitely 
incompatible with pqrticipation in all cOinpetitive athleti~s. 
In general, all patients with signific~nt (see later) c~rdiac 
arrhythmias being considered for athletic activity should 
have a 12 lead electrocardiogram, echocardiogram, exerci~e 
test and a long-term ambulatory electrocqrdiogram record•
ing. if possible during tqe specific type of exercise being•
considered. The latter is deemed important because a con•
ventional exercise test may 110t replicate the specific clinical 
situation. In this regard, exercise tests may need to be adapted 
specifically for the athlete; that is, begin exercise at peak 
energy expenditure, as a sprjnter in a race might, rather 
than' with the slow increase in work load commonly used 
in testin~ patients with coronary artery dise~se. Tests in 
addition to these will be mentioned under the specific ar•
r/lythmia discussed. 
All patients with an arrl1Ythmia who are permitted to 
engage in competitive athletics should be reevaluated at 
intervals after they are ';trained," to determif)e whether 
training affected the arrhythmia. It is impo~ant to stress 
that patients whose arrhythmia is controlled by antiar•
rhythmic drugs may stop taking these drugs for a variety of 
rea~ons and therefore compliance with recommended ther•
apy must be established periodiqilly. 
II. Types of Arrhythmias 
A. pisturbances of Sinus Node Function 
Definition and evaluation. Several arrhythmias are in•
c1udeq if) this category. Sinus tachycardia is defined as a 
sif)uS rate either exceeding 100 beats/min or abnormal for 
age in children. 
Sinlls bradycardia is defined as ~ sinus rate less than 60 
bea~s/I11in, with or without junctional escape peats. 
. Sintls arrhythmia is characferized by ph!lsi~ variation in 
sinus cycle length dljrif)g which the maxi!11a\ sinus cycle 
lengt~ ~inus miniI11af sinus cycle lengtp exceeds 120 ms 
or the maximal sinus cyclr length minus ~inimal sinus cycle 
length (Hvicled by the minimal sinus cycle length exceeds 
10%. 
Sinus pause or sinus arrest is recognized by a floncyclical 
pause'in the sinus rnythm in whi<;h the PP interval delimiting 
the pause dqes not eqllal a multiple of the basic PP interval. 
Sinoatrial exit block is defif1ed as the aqseqce of the 
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normally expected P wave producing a pallse, the duration 
of which is of a multiple of the basic PP interval. 
Wandering paq~maker, a variant of sinus arrhythmia, is 
recognized by a cyclic~l increase in the RR interval, a PR 
interval that gradually shortens and may become less than 
120 ms and a change in tre P wave contour that generally 
becomes negative in lea~ I or II, or lost within the QRS 
complex. Usually these chapges occur in reverse as' the 
pacemaker shifts ba~k to tre sinus node. 
. Sick sinus .syndrome (11) is defined as a syndrome en•
compassing sinus node abnorlt)alities that include persistent 
spontaneous sinus bra4ycardi~ not caused by qrugs and in•
appropriate for the physiological circumstance, apparent si•
nu~ arrest or exit block, combinations of sinoatrial and atrio•
ventricular (A V) conduction disturbances or alterations of 
paroX:ysm~ of rapid, regula~' or irregular atrial tachyarrhyth•
mias and periods of slow atria! and ventricular rates (subset 
braqycardia-tachycardia syndrome). 
Sinus tachycardia ang sinus braqycardia appropriate for 
the clinical situation are no~ considered abnormal ancj no 
test~ are necessary. Sinus arrhythmia 'Ind wandering pace•
maker are generally considere9 normal and no tests are 
necessary, up less they result in inappropriately slow rates 
with symptoms. Sinus arrhythmia'and sinus bradycardia are 
common in the trained athiete. . 
Sinus pause or sillUS arrest, sinoatrial exit block and sick 
sinllS syndrome are considered abf10rmal and patients s\1011lcj 
have 12 lead electrocarqiogram., ~4 hour electrocardiogram 
a~d exercise test. Echocarqiography should be performed 
if heart disease is suspe~ted. Other tests to evaluate ven•
tricular or valvular f4nction may be indicated. 
Recommendations. 
I. Patients with a normal qr apnormal heart whose arrhyth•
mia produces no symptoms and does not worsen with 
increased activity can participate in all competitive sports. 
They should be reasse~sed periodically to determine that 
training does not aggr!lvate the bradycardia. 
2. Patients with syncope or presyncope should not partic•
ipate in competitive sports until, the cause has been 
determined. 
I 
3. Patients with symptoms clearly attributed to the arrhyth-
mias should be treated and, if asymptomatic for 6 months, 
may participate in all competitive sports after physician 
reevaluation. 
4. Patients treated with pacemakers should not engage in 
co~petitive sports with a danger of body collision (class 
II). 
B. Premature Atrial Complexes 
Definition and evaluation. This arrhythmia is recog•
nized 6~ a premature P wave with a PR interval exceeding 
120.ms'(eXtept in Wolff-Parkinson-White syndrome, and 
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in children) that mayor may not conduct to the ventricle. 
Premature atrial compiexes may precipitate other 
tachyarrhythmias. 
In the absence of evidehce obtained from a careful history 
or physical examination suggesting the presence of struc•
tural heart disease, and in the absence of symptoms other 
than occasional palpitation, evaluation other than a 12 lead 
electrocardiogram is not riecessary. 
Recommendations. Patients may participate in all com•
petitive sports. 
C. Atrial Flutter 
Definition and evaluation. This arrhythmia is recog•
nized by identically recurring regular sawtooth flutter waves 
that iack an isoelectric interval ordinarily occurring at 300 
beats/min with, in the untreated patient, a ventricular rate 
generally half the atrial rate. 
In the absence of an acute-limiting illness, sustained atrial 
flutter is an uncommon rhythm disturbance in patiertts with•
out structural heart disease. Therefore, an echocardiogram 
should be perfotmed to evaluate cardiovascular function; 
Since the potential for very rapid ventricular rates exists if 
the atrial flutter conducts I: I to the ventricles, determination 
of the ventricular response during an exercise test is essen•
tial. A 12 lead electrocardiogram and long-term electrocar•
diographic recording are also necessary. 
Recommehdations. , 
I. Patients without structural heart disease who maintain a 
ventriculllr rate comparable with that of sinus t~chycardia 
durihg physical activity while receiving therapy with a 
digitalis glycoside and beta-adrenergic receptor ttlocker 
and calcium charinel blocker, or both, may participate 
in low intensity sports (class i.B). However. full partic•
ipation In all competitive sports should not be allowed 
unless the patient has had no episode of atrial flutter for 
6 months with or without treatment. 
2. Patients with structural heart disease may participate ih 
class I.B sports also, although for some, participation ih 
sports such as bowling and cricket should be restricted 
(15). Patients with an abnormal heart may not tolerate 
the increase in ventricular rate. 
D. Atrial Fibrillation 
This condition should be considered in the same way as 
atrial flutter. Other forms of atrial tachycardia including 
automatic atrial tachycardia, atrial tac,hycardiadue to reen•
try, atrial tachycardia with block and chaotic atrial tachy•
cardia should be approached as described for atrial flutter. 
It is assumed in each instance that these patients do not 
have Wolff-Parkinson-White syndrome. 
E. AV Junctional Escape Beats 
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This arrhythmia is recognized by pauses in the ventricular 
rhythm exceeding the normal RR interval interrupted by a 
QRS complex of supraventricular configuration. P waves 
may be absent, or have a retrograde or fusion corttour or 
be of sinus origin but not conduct to the ventricle. 
The approach to this rhythm disturbance is an approach 
to the primary problem causing the bradycardia that per•
mitted the escape beats. Junctional escape beats are fairly 
common, particularly in trained athletes. 
F. AV Junctional Escape Rhythm 
This arrhythmia is recognized by two or more consec•
utive junctional escape beats at a rate that is slower than 
the usual sinus rate for age, that is, less than 60 beats/min 
in adults. It is not uncommon in trained athletes. 
The clinical approach and final recommendation are the 
same as for sick sinus syndrome (section A). 
G. Premature AV Junctional Complexes 
Definition and evaluation. This condition is recognized 
electrocardiographically by a premature QRS complex ~ith 
a supraventricular contour that mayor may not conduct 
retrogradely to the atrium. If the patient is asymptomatic 
except for occasional episodes of palpitation that do not 
suggest a sustained tachycardia, evaluation rieed include 
only a 12 lead electrocardiogram. A 24 hour electrocardio•
graphic recording, during athletic activity if possible, an 
echocardiogram and an exercise test may be indicated in 
some patients. 
It.ecommendatioris. 
I. Patients who have a normal heart without evidence of a 
sustained tachycardia can participate in all competitive 
sports. 
2. Patients with an aonormal lieart, depending on the type 
and extent of heart disease, may participate in low in•
tensity competitive sports (class I.E). 
H. Nonparoxysmal AV Junctional Tachycardia 
Definition and evaluation. This arrhythmia is recog•
nized by a QRS compiex of supraventricular configuration 
at a fairly regular rate of 70 to 130 beats/min. The atria 
may be captured retrogradely or may discharge indepen•
dently. Nonparoxysmal A V junctional tachycardia occurs 
most commonly ih patients with heart disease such as in•
ferior myocardial infarction or myocarditis or after cardiac 
surgery. Excessive digitalis is an important cause. Thus, 
most of the episodes are [eiated to a transient event. Per•
sistence of nonparoxystnal A V junctional tachycardia can 
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occur in healthy individuals without symptoms or can be a 
serious and difficult to control tachyarrhythmia, occasion•
ally chronic and long lasting (16). 
Noninvasive tests required include a 12 lead electrocar•
diogram, echocardiogram exercise test and 24 hour electro•
cardiographic recording during activity. 
Recommendations. 
1. Patients without structural heart disease or symptoms 
who have a controlled ventricular rate with or without 
therapy can participate in all competitive sports. 
2. Patients with structural heart disease or incompletely 
controlled ventricular rates, depending on the nature and 
extent of the structural heart disease and ventricular rate, 
may engage in low intensity competitive sports (class 
I.B). 
I. Supraventricular Tachycardia 
Definition and evaluation. Patients with A V nodal 
reentrant tachycardia, reentry over a (concealed) accessory 
pathway with retrogradely conduction and sinus nodal reen•
try (17-19) are included in this category. 
Reentrant tachycardia in the A V node is characterized 
by a tachycardia with a QRS complex of supraventricular 
origin, with sudden onset and termination generally at rates 
between 150 and 250 beats/min and with a regular rhythm. 
Atrial activity during tachycardia may not be apparent in 
the routine scalar electrocardiogram in many patients. Some 
of these patients may have a short PR interval during sinus 
rhythm and are often categorized together as having the 
Lown-Ganong-Levine syndrome, and their AV node may 
conduct impulses more rapidly than the A V node of patients 
with a normal PR interval. Some of these patients may have 
supraventricular tachycardia or atrial fibrillation with more 
rapid ventricular rates than those in patients with normal 
PR intervals. 
The presence of an accessory pathway that conducts uni•
directionally from the ventricle to the atrium but not in the 
reverse direction is not apparent in the scalar electrocardio•
gram during sinus rhythm because the ventricle is not pre•
excited. Electrocardiographically, a tachycardia due to this 
mechanism may be suspected when the QRS complex is 
normal and the retrograde P wave, often negative in lead 
I, occurs in the ST segment or early T wave after completion 
of the QRS complex. These findings do not unequivocally 
exclude A V nodal reentry, however. Rates are generally in 
the range of 200 beats/min. 
Sinus nodal reentry is recognized by P waves identical 
or very similar to the sinus P wave morphologically and a 
PR interval related to the tachycardia rate but generally fairly 
close to normal, with an average ventricular rate of 130 to 
140 beats/min. These average rates during supraventricular 
tachycardia may be faster in children. 
Noninvasive tests include a 12 lead electrocardiogral}1, 
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a 24 hour electrocardiographic recording during athletic ac•
tivity, an echocardiogram and an exercise test. 
If the diagnosis of the supraventricular tachycardia cannot 
be made with certainty and other clinical circumstances 
warrant it, invasive electrophysiologic studies may be in•
dicated. It is very important to know the rate response of 
the supraventricular tachycardia during exercise. If the ex•
ercise does not induce the tachycardia, attempts to induce 
the supraventricular tachycardia, possibly with atrial or 
esophageal pacing may be useful, followed by exercising 
the patient during supraventricular tachycardia. 
Recommendations. 
1. Patients with reproducible exercise-induced supraven•
tricular tachycardia in whom prevelltion of recurrences 
has been achieved may participate in all competitive 
sports. 
2. Patients who do not have exercise-induced supraven•
tricular tachycardia but suffer from sporadic recurrences 
should have an attempt at prevention. However, because 
of the unpredictable nature of the tachycardia, they can 
participate in low intensity competitive sports (class I.B), 
particularly if there is minimal or no structural heart 
disease and the ventricular rate remains less than 200 to 
250 beats/min (dependent on the patient's age) with ex•
ertion. However, therapy should be considered. 
3. Patients with syncope or presyncope or significant struc•
tural heart disease should not participate in any com•
petitive sports until they have been adequately treated 
and have no recurrence for at least 6 months. 
J. Ventricular Pre-excitation 
Definition and evaluation. This condition is docu•
mented electrocardiographically when the PR interval is less 
than 120 ms during sinus rhythm and the QRS complex 
duration exceeds 120 ms and has a slurred, slowly rising 
onset and secondary ST -T wave changes (20). The term 
"Wolff-Parkinson-White syndrome" is applied when the 
patient has symptoms generally due to tachyarrhythmias. 
The most common tachycardia is characterized by a normal 
QRS complex with ventricular rates of 150 to 250 beats/min 
due to anterograde conduction over the normal A V pathway 
alld retrograde conduction over the accessory pathway. In 
addition, a smaller percent of patients may have atrial flutter 
or atrial fibrillation. 
Required noninvasive tests include a 12 lead electrocar•
diogram, a 24 hour electrocardIographic recording during 
athletic activity, exercise test and echocardiogram because 
some patients may have associated cardiovascular ab•
normalities. 
In asymptomatic patients with no structural cardiac ab•
normalities and no history of tachycardia, further evaluation 
may not be necessary. Sudden death in patients with pre•
excitation is rare, and it appears to be confined largely to 
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those patients with accessory pathways that have short re•
fractory periods, Therefore it may be advisable in selected 
patients, even if asymptomatic, to undertake appropriate 
evaluations to identify the presence of an accessory pathway 
that has a short refractory period. However, in patients who 
have a history of palpitation, syncope or presyncope, an 
assessment of functional capabilities and electrophysiologic 
properties of the accessory pathway is mandatory. This may 
be done in some patients during esophageal pacing or by 
an intracardiac electrophysiologic study. Atrial fibrillation 
should be induced and the shortest RR interval assessed. 
Recommendations. 
I. Patients without structural heart disease and no history 
of palpitation or tachycardia, particularly in older age 
groups, can participate in all competitive sports. How•
ever, in younger age groups, a more in-depth evaluation 
may be recommended before participation in moderate 
to high intensity sports, 
2. Patients whose shortest RR interval during atrial fibril•
lation exceeds 300 ms or whose accessory pathway re•
fractory period exceeds 220 ms during isoproterenol 
administration should be managed as discussed under 
atrial flutter or supraventricular tachycardia. 
3. Patients whose shortest RR interval during atrial fibril•
lation is less than 300 ms or whose refractory period of 
the accessory pathway is less than 200 ms have the threat 
of very rapid ventricular rates, Untreated patients with 
Wolff-Parkinson-White syndrome should not participate 
in competitive sports. Patients in whom these values can 
be lengthened by drug administration may participate in 
low intensity sports (class I. 8). 
K, Premature Ventricular Complexes 
Definition and evaluation. This condition is character•
ized by premature QRS complexes, not conducted from the 
atrium or A V junction, bizarre in shape with a duration 
generally exceeding 120 ms and secondary ST -T wave 
changes. 
Noninvasive tests recommended include a 12 lead elec•
trocardiogram and exercise test. If there is evidence to sug•
gest the presence of structural heart disease, an echocar•
diogram and a 24 hour electrocardiographic recording may 
be beneficial. Even without evidence of structural heart dis•
ease, if an increase in the number of premature ventricular 
complexes occurs during exercise, further evaluation may 
be indicated. In patients with multiform premature ventric•
ular complexes, or pairs of such complexes, hemodynamic 
catheterization may be recommended to exclude the pres•
ence of structural heart disease. In some of these patients 
thought to have a normal heart, catheterization may reveal 
abnormalities including occult coronary artery disease, ar-
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rhythmogenic right ventricular dysplasia, cardiac tumor or 
early cardiomyopathy. 
Recommendations. 
I. Patients with no structural heart disease in whom pre•
mature ventricular complexes disappear during exercise 
or at least do not increase in frequency can participate 
in all competitive sports. 
2. Patients in whom premature ventricular complexes in•
crease in frequency or occur in pairs during exercise 
testing may still have "benign" premature ventricular 
complexes that do not indicate underlying structural heart 
disease. They can participate in low intensity competitive 
sports (class I. 8). However, caution is indicated before 
allowing full participation in high to moderate intensity 
competitive sports. 
3. Patients with structural heart disease who are in high 
risk groups should be excluded from high to moderate 
intensity competitive sports with or without treatment. 
These patients include those who have had a right ven•
triculotomy for repair of congenital heart disease, sig•
nificant degrees of aortic stenosis, aortic insufficiency, 
coronary artery disease and cardiomyopathies. Patients 
in whom premature ventricular complexes are suppressed 
may participate in low intensity sports (class 1.8). 
4. Patients who have premature ventricular complexes and 
congenital or idiopathic prolonged QT interval should 
not participate in competitive sports. 
5. Patients who have premature ventricular complexes and 
abnormal hearts but not in the categories indicated above 
may participate in low intensity competitive sports (class 
I.8). 
L. Ventricular Tachycardia 
Definition and evaluation. This arrhythmia is charac•
terized by a series of three or more bizarrely shaped pre•
mature ventricular complexes that exceed 120 ms in duration 
with secondary ST-T wave changes (21-25). Ventricular 
tachycardia includes subsets such as accelerated idioven•
tricular rhythm, torsade de pointes (26), bidirectional ven•
tricular tachycardia and repetitive monomorphic ventricular 
tachycardia. 
Ventricular tachycardia is always a potentially serious 
problem and merits 3 to 6 months of observation initially. 
Noninvasive tests to be performed include a 12 lead elec•
trocardiogram, an exercise test, a 24 hour electrocardio•
graphic recording during exercise and an echocardiogram. 
Cardiac catheterization should be considered to be certain 
that the heart is structurally normal. 
Recommendations. 
I. Patients who have no syncope or presyncope, no struc•
tural heart disease and a non sustained ventricular tachy-
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cardia of uniform configuration that does not exceed 150 
beats/min during maximal exercise may participate in all 
competitive sports with caution. 
2. Patients who have structural heart disease, a history of 
syncope or pre syncope , a ventricular tachycardia ex•
ceeding 150 beats/min during exertion or the long QT 
interval syndrome may not engage in any competitive 
sports. 
3. Patients in whom antiarrhythmic drug therapy prevents 
a recurrence of syncope or presyncope for at least 6 
months with no documented episode of sustained ven•
tricular tachycardia or if antiarrhythmic drug therapy 
prevents ventricular tachycardia rates from exceeding 
150 beats/min during exertion may participate in low 
intensity competitive sports (class 1.8), unless patients 
are in the high risk groups discussed under premature 
ventricular complexes. Regardless of treatment, patients 
with the long QT syndrome (27) and ventricular tachy•
cardia should not participate in any competitive sports. 
M. Ventricular Flutter and Ventricular Fibrillation 
Patients with these conditions which result in cardiac 
arrest in the presence or absence of structural heart disease 
cannot participate in any competitive sports. However, se•
lected patients who have been appropriately evaluated and 
treated may engage in low intensity competitive sports (class 
1.8). 
N. First Degree AV Heart Block 
Definition and evaluation. This condition is character•
ized by a PR interval exceeding 200 ms. If the QRS complex 
is normal, no further eval uation other than a 12 lead is 
necessary. If the QRS complex is abnormal or the PR in•
terval is excessively prolonged (that is, > 0.5 seconds), a 
stress test, a 24 hour electrocardiographic recording and an 
echocardiogram are indicated. 
Recommendations. Patients who are asymptomatic and 
have no structural heart disease and in whom the first degree 
heart block does not worsen with exercise may participate 
in all competitive sports. The nature and extent of underlying 
heart disease may require some restrictions. 
O. Type 1 Second Degree (Wenckebach) AV Block 
Definition and evaluation. This condition is repre•
sented by progressive prolongation of the PR interval cul•
minating in a nonconducted P wave. Recommended tests 
include a 12 lead electrocardiogram and an exercise test. A 
24 hour electrocardiographic recording during a episode of 
athletic activity and an echocardiogram may be indicated in 
some patients. 
Recommendations. 
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1. Patients who have a normal heart and no worsening of 
the block with exercise may participate in all competitive 
sports. 
2. Patients who have an abnormal heart and whose arrhyth•
mias disappear with exercise without marked sinus slow•
ing or worsening of the type 1 second degree heart block 
during or after exercise may be permitted to participate 
in all competitive sports with caution. 
3. Patients whose second degree A V block does not dis•
appear during exercise testing or appears or worsens 
during exercise testing or the recovery period may par•
ticipate in moderate intensity competitive sports without 
pacemaker implantation. 
P. Type 2 Second Degree (Mobitz) AV Block 
This block is characterized electrocardiographically by a 
QRS complex of prolonged duration, fixed PR interval cul•
minating in one (or several) nonconducted P waves. 
This abnormality is considered as in acquired complete 
heart block. 
Q. Acquired Complete Heart Block 
This condition is characterized as an acquired abnor•
mality having no P waves conducting to the ventricles and 
generally a wide QRS ventricular escape rhythm. It should 
be treated with pacing (see section R, Recommendations 2 
and 3) prior to any athletic activity. 
R. Congenital Complete Heart Block 
Definition and evaluation. Congenital complete heart 
block electrocardiographically is present when no atrial ac•
tivity conducts to the ventricle, generally with a normal 
QRS contour escape rhythm. The clinical approach to eval•
uating the severity of the cardiovascular abnormality in•
cludes a 12 lead electrocardiogram, a 24 hour electrocar•
diographic recording, an exercise test and an echocardiogram. 
Exercise testing should be done to the same exercise level 
as during exercise. 
Recommendations. 
1. Patients with a normal heart, no history of syncope or 
presyncope, a narrow QRS complex, ventricular rates at 
rest of greater than 40 to 50 beats/min increasing to 70 
to 80 beats/min with exertion and no ventricular ectopic 
activity during exertion may participate in all competitive 
sports (28). 
2. Patients with ventricular arrhythmias, symptoms of fa•
tigue, presyncope or syncope during activity should have 
an atrial synchronous pacemaker implanted before they 
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can participate in competitive sports. They may partic•
ipate in low intensity competitive sports (class I. B) if 
the ventricular arrhythmia can be controlled. Also. they 
may not engage in competitive sports with a danger of 
body collision (class II). 
3. Patients with an abnormal heart may not participate in 
any competitive sports without a pacemaker. Restrictions 
are the same as above. 
S. Complete Right Bundle Branch Block 
Definition and evaluation. This block is characterized 
by supraventricular beats conducted with delay in right ven•
tricular activation and a QRS duration equal to or exceeding 
120 ms. Evaluation includes a 12 lead electrocardiogram, 
a 24 hour electrocardiographic recording, an exercise test 
and an echocardiogram. 
Recommendations. Patients who have no ventricular 
arrhythmias, symptoms or heart disease can participate in 
all competitive sports. 
T. Complete Left Bundle Branch Block 
Definition and evaluation. This block is characterized 
electrocardiographically by supraventricular beats con•
ducted with delay in left ventricular activation and a QRS 
complex of 120 ms or greater in duration. 
The evaluation includes a 12 lead electrocardiogram, a 
24 hour electrocardiographic recording, an exercise test and 
an echocardiogram. Because of the rarity of acquired left 
bundle branch block in children and its association with 
syncope from presumed paroxysmal A V block, an invasive 
electrophysiologic study should be considered (29). Ac•
quired left bundle branch block in older patients should be 
considered as those with right bundle branch block. 
Recommendations. 
I. Patients with a normal conduction response to pacing 
can participate in all competitive sports. 
2. Patients with abnormal conduction should have pace•
maker implantation. They may not participate in sports 
with danger of body contact (class II). 
U. Congenital Long QT Syndrome 
Definition and evaluation. The diagnosis of the long 
QT-QTU syndrome rests on corrected QT intervals of greater 
than 450 to 500 ms. However, it must be stressed that the 
QT interval may be variable and normal at times. Therefore 
a family history of the syndrome or a history of syncope or 
presyncope, or both, should be sought. It is important to 
stress that minor degrees of QT prolongation not be 
overinterpreted. 
Evaluation of this cardiovascular abnormality requires a 
TASK FORCE VI 
ARRHYTHMIAS 
1231 
12 lead electrocardiogram, a 24 hour electrocardiographic 
recording and an exercise test. To eliminate associated struc•
tural abnormalities, an echocardiogram is recommended. 
Recommendations. Some patients with the prolonged 
QT or QTU interval syndrome are at risk for sudden death 
with activity; such patients should be restricted from all 
competitive sports. 
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